يعرض 1 - 10 نتائج من 64 نتيجة بحث عن '"DISEASES::Male Urogenital Diseases::Urologic Diseases::Kidney Diseases::Renal Insufficiency::Renal Insufficiency"', وقت الاستعلام: 0.83s تنقيح النتائج
  1. 1
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Casal Moura M Division of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA. Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA. Zubidat D, Zand L Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA. Patricio Liebana M, Jose Soler M Servei de Nefrologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Sethi S Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA. Leon-Roman J Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA. Servei de Nefrologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Kidney International Reports;9(5); https://doi.org/10.1016/j.ekir.2024.02.1431Test; Casal Moura M, Zubidat D, Liebana MP, Sethi S, Soler MJ, Zand L, et al. Predictive Factors of Renal Recovery and Progression to End-Stage Kidney Disease in Patients With Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis With Severe Kidney Disease. Kidney Int Reports. 2024 Mar;9(5):1284–97.; https://hdl.handle.net/11351/11487Test

  2. 2
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Llàcer P Internal Medicine Department, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain. Department of Medicine and Medical Specialties, Facultad de Medicina y Ciencias de la Salud, Universidad de Alcalá, Madrid, Spain. Cobo Marcos M Department of Cardiology, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain. Centro de Investigación Biomédica en Red en Enfermedades Cardiovasculares, Madrid, Spain. de la Espriella R Department of Cardiology, Hospital Clínico Universitario de Valencia, Valencia, Spain. Gayán Ordás J Department of Cardiology, Hospital Universitario Arnau de Vilanova, Institut de Recerca Biomèdica de Lleida, Lleida, Spain. Zegri I Department of Cardiology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. Fort A Department of Cardiology, Hospital Universitari Dr Josep Trueta, Girona, Spain. Méndez A Servei de Cardiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Soler MJ Servei de Nefrologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Clinical Kidney Journal;17(6); https://doi.org/10.1093/ckj/sfae140Test; Llàcer P, Cobo Marcos M, De La Espriella R, Gayán Ordás J, Zegri I, Fort A, et al. Congestion as a crucial factor determining albuminuria in patients with cardiorenal disease. Clin Kidney J. 2024 May15;17(6):140.; https://hdl.handle.net/11351/11571Test

  3. 3
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Moreno-Pérez O Department of Endocrinology and Nutrition, General University Hospital Dr Balmis of Alicante, Institute of Health and Biomedical Research of Alicante (ISABIAL), Alicante, Alicante, Spain. Department of Clinical Medicine, Miguel Hernández University, San Juan, Alicante, Spain. Reyes-García R Endocrinology Unit, University Hospital of Torrecárdenas, Almería, Almería, Spain. CIBER de Fragilidad y Envejecimiento Saludable “CIBERFES”, Instituto de Salud Carlos III, Madrid, Spain. Modrego-Pardo I Department of Endocrinology and Nutrition, University Hospital Marina Baixa, Villajoyosa, Alicante, Spain. López-Martínez M, Soler MJ Servei de Nefrologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Centro de Referencia en Enfermedad, Glomerular Compleja del Sistema Nacional de Salud de España (CSUR), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Clinical Kidney Journal;17(4); https://doi.org/10.1093/ckj/sfae039Test; Moreno-Pérez O, Reyes-García R, Modrego-Pardo I, López-Martínez M, Soler MJ. Are we ready for an adipocentric approach in people living with type 2 diabetes and chronic kidney disease? Clin Kidney J. 2024 Feb 21;17(4):39.; https://hdl.handle.net/11351/11302Test

  4. 4
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Quiroga B IIS-La Princesa, Nephrology Department, Hospital Universitario de la Princesa, Madrid, Spain. Soler MJ Servei de Nefrologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. RICORS2040 (Kidney Disease), Spain. Ortiz A IIS-La Princesa, Nephrology Department, Hospital Universitario de la Princesa, Madrid, Spain. de Sequera P RICORS2040 (Kidney Disease), Spain. Nephrology Department, Hospital Universitario Infanta Leonor – Universidad Complutense de Madrid, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Nefrología;43(6); https://doi.org/10.1016/j.nefroe.2023.04.005Test; Quiroga B, Soler MJ, Ortiz A, de Sequera P. Lessons from SENCOVAC: A prospective study evaluating the response to SARS-CoV-2 vaccination in the CKD spectrum. Nefrología (Eng Ed). 2023 Nov-Dec;43(6):676–87.; https://hdl.handle.net/11351/11003Test

  5. 5
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Górriz JJ Servicio de Nefrología, Hospital Clínico Universitario de Valencia, Universidad de Valencia, Valencia, Spain. González-Juanatey JR Servicio de Cardiología, Hospital Clínico Universitario Santiago de Compostela, Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares (CIBERCV), Santiago de Compostela, Spain. Facila L Servicio de Cardiología, Consorcio Hospital General Universitario de Valencia, Valencia, Spain. Soler MJ Servei de Nefrologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Valle A Servicio de Cardiología, Hospital La Salud, Valencia, Spain. Ortiz A Servicio de Nefrología, Fundación Jiménez Díaz, Madrid, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Nefrología (English Edition);43(4); https://doi.org/10.1016/j.nefroe.2023.09.002Test; Górriz JL, González-Juanatey JR, Facila L, Soler MJ, Valle A, Ortiz A. Finerenone: towards a holistic therapeutic approach to patients with diabetic kidney disease. Nefrologia (Eng Ed). 2023 Jul-Aug;43(4):383–516.; https://hdl.handle.net/11351/10890Test

  6. 6
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, González-Juanatey JR Cardiology Department, Hospital Clínico Universitario Santiago de Compostela, Centro de investigación Biomédica en Red Enfermedades Cardiovasculares (CIBERCV), Santiago de Compostela, Spain. Górriz JL Nephrology Department, Hospital Clínico Universitario de Valencia, Universidad de Valencia, Valencia, Spain. Ortiz A Nephrology Department, Fundación Jiménez Díaz, Madrid, Spain. Valle A Cardiology Department, Hospital La Salud, Valencia, Spain. Soler MJ Servei de Nefrologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Facila L Cardiology Department, Consorcio Hospital General Universitario de Valencia, Valencia, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Annals of Medicine;55(1); https://doi.org/10.1080/07853890.2023.2171110Test; González-Juanatey JR, Górriz JL, Ortiz A, Valle A, Soler MJ, Facila L. Cardiorenal benefits of finerenone: protecting kidney and heart. Ann Med. 2023 Jan 31;55(1):502–13.; https://hdl.handle.net/11351/9108Test; 000919979500001

  7. 7
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Rico-Fontalvo J Asociación Colombiana de Nefrología e Hipertensión, Bogotá, Colombia. Machado M Universidade do Vale do Itajaí, Itajaí, Brazil. López-Martínez M, Soler MJ Servei de Nefrologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Kidney International Reports;8(11); https://doi.org/10.1016/j.ekir.2023.08.011Test; Rico-Fontalvo J, Machado M, López-Martínez M, Soler MJ. Obesity Weight Loss Phenotypes in CKD: Measured GFR and Albumin-to-Creatinine Excretion Ratio Place for Stratification. Kidney Int Reports. 2023 Nov;8(11):2492.; https://hdl.handle.net/11351/10740Test

  8. 8
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Werfel L Department of Human Genetics, Hannover Medical School, Hannover, Germany. Department of Pediatric Kidney, Liver and Metabolic Diseases, Hannover Medical School, Hannover, Germany. Martens H Department of Human Genetics, Hannover Medical School, Hannover, Germany. Hennies I, Fröde K Department of Pediatric Kidney, Liver and Metabolic Diseases, Hannover Medical School, Hannover, Germany. Gjerstad AC Division of Pediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway. Altarescu G Medical Genetics Institute, Shaare Zedek Medical Center, Jerusalem, Israel. Valenzuela Palafoll I Àrea de Genètica Clínica i Molecular, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Kidney International Reports;8(11); https://doi.org/10.1016/j.ekir.2023.08.008Test; Werfel L, Martens H, Hennies I, Gjerstad AC, Fröde K, Altarescu G, et al. Diagnostic Yield and Benefits of Whole Exome Sequencing in CAKUT Patients Diagnosed in the First Thousand Days of Life. Kidney Int Reports. 2023 Nov;8(11):2439–57.; https://hdl.handle.net/11351/10741Test; 001109004400001

  9. 9
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Teixido-Trujillo S Universidad de La Laguna, Faculty of Medicine, San Cristóbal de La Laguna, Spain. Research Unit, Hospital Universitario de Canarias, San Cristóbal de La Laguna, Spain. Luis-Lima S Department of Laboratory Medicine, Complejo Hospitalario Universitario de Canarias, San Cristóbal de La Laguna, Spain. López-Martínez M Servei de Nefrologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Navarro-Díaz M Department of Nephology, Hospital de Sant Joan Despí Moisès Broggi, Barcelona, Spain. Díaz-Martín L Research Unit, Hospital Universitario de Canarias, San Cristóbal de La Laguna, Spain. Instituto de Tecnologías Biomédicas (ITB), Universidad de la Laguna, San Cristóbal de La Laguna, Spain. Escasany-Martínez E Lipobeta group. Departamento de Ciencias Básicas de la Salud, Facultad de Ciencias de la Salud, Universidad Rey Juan Carlos, Madrid, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Pflügers Archiv European Journal of Physiology;475; https://doi.org/10.1007/s00424-023-02841-9Test; Teixido-Trujillo S, Luis-Lima S, López-Martínez M, Navarro-Díaz M, Díaz-Martín L, Escasany-Martínez E, et al. Measured GFR in murine animal models: review on methods, techniques, and procedures. Pflügers Arch. 2023 Nov;475:1241–50.; https://hdl.handle.net/11351/10507Test; 001044325600001

  10. 10
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Fernández-Fernandez B, Ortiz A Department of Nephrology and Hypertension, IIS-Fundacion Jimenez Diaz UAM, Madrid, Spain. RICORS2040, Madrid, Spain. Departamento de Medicina, Facultad de Medicina, Universidad Autónoma de Madrid, Madrid, Spain. GEENDIAB, Sociedad Española de Nefrología, Spain. Sarafidis P Department of Nephrology, Hippokration Hospital, Aristotle University of Thessaloniki, Greece. Soler MJ RICORS2040, Madrid, Spain. GEENDIAB, Sociedad Española de Nefrología, Spain. Servei de Nefrologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Clinical Kidney Journal;16(8); https://doi.org/10.1093/ckj/sfad082Test; Fernández-Fernandez B, Sarafidis P, Soler MJ, Ortiz A. EMPA-KIDNEY: expanding the range of kidney protection by SGLT2 inhibitors. Clin Kidney J. 2023 Aug;16(8):1187–98.; https://hdl.handle.net/11351/10204Test; 001018798700001